Assignee
OBLIQUE THERAPEUTICS AB
SE·8 granted patents·5 pending applications·8 citations·filing 2016–2021
Top patents by PatentIndex Score
13 records- 0184US11912765B2Methods for epitope selectionOBLIQUE THERAPEUTICS AB·Filed 2021·Granted Feb 27, 2024·1 cites·35 claims
- 0284US11208384B2Sulfinylpyridines and their use in the treatment of cancerOBLIQUE THERAPEUTICS AB·Filed 2018·Granted Dec 28, 2021·2 cites·17 claims
- 0380US11161815B2Hydrocarbylsulfonyl-substituted pyridines and their use in the treatment of cancerOBLIQUE THERAPEUTICS AB·Filed 2018·Granted Nov 2, 2021·2 cites·10 claims
- 0467US11408883B2Multi-protease methodOBLIQUE THERAPEUTICS AB·Filed 2017·Granted Aug 9, 2022·1 cites·19 claims
- 0567US11168069B2Heterocyclylsulfonyl-substituted pyridines and their use in the treatment of cancerOBLIQUE THERAPEUTICS AB·Filed 2018·Granted Nov 9, 2021·1 cites·15 claims
- 0665US11028067B2Heteroarylsulfonyl-substituted pyridines and their use in the treatment of cancerOBLIQUE THERAPEUTICS AB·Filed 2018·Granted Jun 8, 2021·1 cites·18 claims
- 0763US2022177430A1Sulfinylpyridines and their use in the treatment of cancerOBLIQUE THERAPEUTICS AB·Filed 2021·Application pending·0 cites
- 0861US2022119348A1Hydrocarbylsulfonyl-substituted pyridines and their use in the treatment of cancerOBLIQUE THERAPEUTICS AB·Filed 2021·Application pending·0 cites
- 0956US11161901B2Methods for epitope selectionOBLIQUE THERAPEUTICS AB·Filed 2016·Granted Nov 2, 2021·0 cites·35 claims
- 1049US2024052027A1Trpv1 epitopes and antibodiesOBLIQUE THERAPEUTICS AB·Filed 2021·Application pending·0 cites
- 1146US12590147B2TRPV1 epitopes and antibodiesOBLIQUE THERAPEUTICS AB·Filed 2020·Granted Mar 31, 2026·0 cites·10 claims
- 1244US2023109318A1Kras epitopes and antibodiesOBLIQUE THERAPEUTICS AB·Filed 2021·Application pending·0 cites
- 1333US2019194320A1Methods of identifying epitopesOBLIQUE THERAPEUTICS AB·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when OBLIQUE THERAPEUTICS AB files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →